TT

T. Tyler Luyben

Scientist and Principal at Sixty Degree Capital

Toronto, Ontario

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Principal

    2021

    • Developing a deep understanding of investment focus, platform, the venture industry, and mission. • Primary source of support for the investment team by acting as a science and market expert, helping them navigate questions, bugs, and issues. • Have a direct line of sight to all deals and research on any assigned scientific areas and write scientific due diligence reports. • Conducting technology validation, competitor benchmarking and market research. • Researching in the healthcare space to identify new trends in health innovation. • Meeting frequently with scientific team members and present research results. • Performing top-down screening on new investment areas and screen deal pipelines. • Reviewing Legal documents related to deal closing.

2018 - 2020

  • Drug Development Associate

    2018 - 2020

    Responsible for working on Edesa’s clinical development projects. Duties and Responsibilities: • Developed and executed clinical development plans for all of Edesa’s assets • Developed and successfully executed regulatory filings for HC and FDA • Worked with CDMO managing manufacturing clinical batches of drug product and substance • Developed pre-clinical testing and design programs for Edesa’s pipeline products • Prepared and presented updates for the management team and board of directors • Coordinated business development deals at major international conferences including AAD and ACDS • Liaised with MD KOLs to develop protocols and clinical trial design.

  • Postdoctoral Researcher

    2017 - 2018

    Continuing my PhD work on the basic problems of memory using cutting-edge imaging technology and primary culture assays. • Planned and executed cutting-edge research on memory formation • Collaborated internationally with labs from Japan • Developed and maintained multiple novel transgenic mouse lines • Published original research in rigorous peer-reviewed journals such as Cell and PNAS

  • Doctoral Student

    2011 - 2017

    • Joined as M.Sc. student, promoted to Ph.D. student rapidly through a qualification exam based on strong scientific, presentation, and writing ability. • Developed a novel light-based treatment modality for Alzheimer’s and dementia • Mentored new students and taught an advanced course in microscopy at the graduate level. • Won multiple awards including the Ontario Graduate Scholarship (2015) and OSOTF (2013, 2015) • Presented original research at major international research conferences

  • Summer Lab Student

    2009 - 2009

    Re-hired as part of Dr. Hegele’s Hyperlipidemia genotyping research in the DNA sequencing facility. In addition to customer samples, also participated in a Hyperlipidemia GWAS. • Responsible for genotyping >200 hyperlipidemia patients • Maintained >300 Hutterite DNA long-term storage samples • Completed >1,000 reactions for customers and GWAS

  • Summer Student

    2006 - 2006

    Hired while still in high school to Dr. Rob Hegele's lab, focusing on studying hyperlipidemia. I ran PCR and gel electrophoresis of patient/control DNA as well as Nanospec archiving stock DNA from Hutterite patients.